SCHEMBL2775265

SCHEMBL2775265

CCc1c(C)nn(-c2c(Cl)cccc2Cl)c1COc1ccc(CNCc2ccc(C(=O)O)cc2)c(C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
PPARA Q07869 1/20 0.42
MRGPRX4 Q96LA9 1/20 0.41
PDGFRA P16234 1/20 0.39
S1PR1 P21453 1/20 0.39
ROCK1 Q13464 1/20 0.39
S1PR5 Q9H228 1/20 0.39
NR1H4 Q96RI1 4/20 0.39
KDM4E B2RXH2 2/20 0.39
NR4A2 P43354 1/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.38
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
RXRG P48443 1/20 0.38
P4HB P07237 1/20 0.38
GCK P35557 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2772063 0.94 PPARA (0.43) SMN1; SMN2NPSR1PPARAMRGPRX4PDGFRA
SCHEMBL2773812 0.93 MRGPRX4 (0.48) SMN1; SMN2NPSR1PPARAMRGPRX4NR1H4
SCHEMBL2770719 0.91 SMN1; SMN2 (0.41) SMN1; SMN2NPSR1PPARAMRGPRX4PDGFRA
SCHEMBL2775204 0.87 MRGPRX4 (0.47) SMN1; SMN2PPARAMRGPRX4S1PR1S1PR5
SCHEMBL2771623 0.86 NR1H4 (0.46) SMN1; SMN2NPSR1PPARAMRGPRX4PDGFRA
SCHEMBL2770433 0.84 MRGPRX4 (0.47) PPARAMRGPRX4NR1H4NR4A2
SCHEMBL2775269 0.84 NR1H4 (0.47) PPARAMRGPRX4NR1H4NR4A2KMT2A
SCHEMBL2773781 0.83 NR1H4 (0.45) MRGPRX4NR1H4NR4A2RXRARXRB
SCHEMBL498301 0.83 NR1H4 (0.59) SMN1; SMN2NPSR1PPARAMRGPRX4PDGFRA
SCHEMBL2770618 0.83 NR1H4 (0.58) SMN1; SMN2NPSR1PPARAMRGPRX4PDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029547-B1 FXR AGONISTS LILLY CO ELI (US) 2010-04-28 EP disclosed